This archive contains the following articles listed by volume, issue and page number:
 |
|
|
Volume 8, 2004 Articles |
Title (Click for Details) |
Vol/Issue |
Page |
Prescription-Who and/or What is IJPC and the subject of pharmacy practice and compounding pharmacy-From the Editor |
Vol. 8 No. 1 |
2 |
Book & Literature Reviews |
Vol. 8 No. 1 |
4 |
Women's Oral Health: Is There a Hormonal Link? |
Vol. 8 No. 1 |
10 |
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1 |
Vol. 8 No. 1 |
16 |
Prevention Is the Best Medicine: Don J. Bottoni, RPh, FACA, FIACP |
Vol. 8 No. 1 |
22 |
Detailing Your Compounding Specialty Practice: Part 1 - Prospecting, Preapproach and Approach |
Vol. 8 No. 1 |
31 |
Developing and Providing Compounding Services for Hospitals Involved in a Merger |
Vol. 8 No. 1 |
36 |
American Pharmaceutical Patents From a Historical Perspective |
Vol. 8 No. 1 |
40 |
Basics of Compounding for Disorders of the External Ear |
Vol. 8 No. 1 |
46 |
Urea and Hydrogen Peroxide Otic Solution |
Vol. 8 No. 1 |
47 |
Boric Acid 2% in Isopropyl Alcohol |
Vol. 8 No. 1 |
47 |
Aluminum Acetate Otic Solution |
Vol. 8 No. 1 |
47 |
Hydrocortisone and Acetic Acid Otic Solution |
Vol. 8 No. 1 |
47 |
Acetic Acid and Glycerin Otic Solution |
Vol. 8 No. 1 |
47 |
Ciprofloxacin 1% Otic Drops |
Vol. 8 No. 1 |
47 |
Gentamicin Sulfate 0.1% Otic Solution |
Vol. 8 No. 1 |
47 |
Lidocaine HCl 0.5% Otic Solution |
Vol. 8 No. 1 |
47 |
Neomycin Sulfate 0.5%, Polymyxin B Sulfate 10,000-U/mL and Hydrocortisone 1% Otic Solution |
Vol. 8 No. 1 |
47 |
Nystatin 100,000-units/mL Otic Suspension |
Vol. 8 No. 1 |
47 |
Triamcinolone 0.1% Otic Solution |
Vol. 8 No. 1 |
47 |
Handling of Syringes and Needles |
Vol. 8 No. 1 |
49 |
Calculations |
Vol. 8 No. 1 |
50 |
Aminopyridine 5-mg Capsules |
Vol. 8 No. 1 |
51 |
Boric Acid 600-mg Vaginal Suppository |
Vol. 8 No. 1 |
52 |
Diaminopyridine 10-mg Capsules |
Vol. 8 No. 1 |
53 |
Glycerin 50% Injection |
Vol. 8 No. 1 |
54 |
Hydrochloric Acid 0.1-N Injection |
Vol. 8 No. 1 |
55 |
Hydrocortisone 2-mg/mL Oral Liquid |
Vol. 8 No. 1 |
56 |
Phenol 5%-in-Oil Injection |
Vol. 8 No. 1 |
57 |
Scopolamine Hydrobromide 0.2% Nasal Spray |
Vol. 8 No. 1 |
58 |
Selegiline HCl 10-mg/mL in Pluronic Lecithin Organogel |
Vol. 8 No. 1 |
59 |
Vancomycin HCl and Heparin Sodium Injection |
Vol. 8 No. 1 |
60 |
Quality-Control Analytical Methods: Selecting an Analytical Method |
Vol. 8 No. 1 |
61 |
Metro Atlanta Board - Certified Specialists' Attitudes Toward Compounding Pharmacy |
Vol. 8 No. 1 |
65 |
Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours |
Vol. 8 No. 1 |
73 |
Scientific and Professional Reviewers for 2002/2003 |
Vol. 8 No. 1 |
77 |
PostScription: The Wedgewood Case: What It Means for Pharmacies |
Vol. 8 No. 1 |
79 |
Prescription - USP <795>, NABP and the Physician/patient/pharmacist relationship - From the Editor |
Vol. 8 No. 2 |
82 |
Literature Reviews |
Vol. 8 No. 2 |
84 |
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists |
Vol. 8 No. 2 |
89 |
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2 |
Vol. 8 No. 2 |
96 |
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs |
Vol. 8 No. 2 |
101 |
Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo. |
Vol. 8 No. 2 |
107 |
Detailing Your Compounding Specialty Practice - Part 2: The Presentation |
Vol. 8 No. 2 |
113 |
Financially Speaking: Business Continuation Planning |
Vol. 8 No. 2 |
120 |
An Excel Spreadsheet for Estimating Sodium-Chloride Equivalents for Drugs |
Vol. 8 No. 2 |
123 |
Basics of Compounding for the Treatment of Warts |
Vol. 8 No. 2 |
126 |
Calibration/Validation of Incubator Temperature |
Vol. 8 No. 2 |
130 |
Calculations |
Vol. 8 No. 2 |
132 |
Dexamethasone 0.04% Topical Spray |
Vol. 8 No. 2 |
133 |
Flucytosine 10-mg/mL Oral Liquid |
Vol. 8 No. 2 |
134 |
Griseofulvin 25-mg/mL Oral Liquid |
Vol. 8 No. 2 |
135 |
Hydromorphone HCl 20-mg/mL and Bupivacaine HCl 7.5-mg/mL Injection |
Vol. 8 No. 2 |
136 |
Miconazole 10-mg Troches |
Vol. 8 No. 2 |
137 |
Netilmicin 0.455% Ophthalmic Solution |
Vol. 8 No. 2 |
138 |
Pyridoxine HCl 100-mg/mL Injection, Preservative Free |
Vol. 8 No. 2 |
139 |
Stomatitis Mouthwash |
Vol. 8 No. 2 |
140 |
Tacrolimus 0.5-mg/mL Oral Liquid |
Vol. 8 No. 2 |
141 |
Tiagabine 1-mg/mL Oral Liquid |
Vol. 8 No. 2 |
142 |
Quality-Control Analytical Methods: Osmolality and Osmometry |
Vol. 8 No. 2 |
143 |
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution |
Vol. 8 No. 2 |
147 |
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion |
Vol. 8 No. 2 |
153 |
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags |
Vol. 8 No. 2 |
156 |
PostScription: Cleanroom Standards |
Vol. 8 No. 2 |
160 |
Prescription - Pharmacy and the United States Pharmaceopeia-National Formulary - From the Editor |
Vol. 8 No. 3 |
162 |
Book and Literature Reviews |
Vol. 8 No. 3 |
164 |
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1 |
Vol. 8 No. 3 |
169 |
Andropause: New Perspectives |
Vol. 8 No. 3 |
175 |
Compounding in the Pharmacy Curriculum: Beyond the Basics |
Vol. 8 No. 3 |
181 |
Migraine Headache Suppositories |
Vol. 8 No. 3 |
184 |
Nitrofurantoin Uretheral Inserts |
Vol. 8 No. 3 |
184 |
Acyclovir Lip Balm |
Vol. 8 No. 3 |
184 |
Gag Tablet Lollipops |
Vol. 8 No. 3 |
184 |
Atropine 1-mg Gelatin Troches |
Vol. 8 No. 3 |
184 |
Phenylpropanolamine HCl 10-mg Chewable Troches for Dogs |
Vol. 8 No. 3 |
184 |
Dicyclomine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches |
Vol. 8 No. 3 |
184 |
Amphotericin B 2-mg/mL Ophthalmic Solution |
Vol. 8 No. 3 |
185 |
Morphine Sulfate 5-mg/0.1-mL Nasal Spray |
Vol. 8 No. 3 |
185 |
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drops |
Vol. 8 No. 3 |
185 |
Nifedipine 20% Vasodilating Gel |
Vol. 8 No. 3 |
185 |
Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel |
Vol. 8 No. 3 |
185 |
Estrogen 0.625-mg/5-g Vaginal Gel |
Vol. 8 No. 3 |
185 |
Clonidine HCl 0.2%/Gabapentin 6%/Ketamine HCl 10% in Pluronic Lecithin Organogel (PLO) |
Vol. 8 No. 3 |
185 |
Pain Management in the Elderly |
Vol. 8 No. 3 |
187 |
Precepting: A Win-Win Situation for All |
Vol. 8 No. 3 |
194 |
A Foot in the Door: Building Relationships Builds Your Business |
Vol. 8 No. 3 |
197 |
Automatic Dishwashers and Detergents in the Pharmacy: The Basics |
Vol. 8 No. 3 |
200 |
Pharmaceutical Compounding Calculations |
Vol. 8 No. 3 |
203 |
Basics of Compounding for Cold Sores or Fever Blisters |
Vol. 8 No. 3 |
206 |
Acyclovir 5%, Lidocaine 1% and Sodium Lauryl Sulfate 5% Medication Stick (Water-soluble base) |
Vol. 8 No. 3 |
208 |
Acyclovir 5%, Lidocaine 1% and Sodium Lauryl Sulfate 5% Medications Stick (Water-proof base) |
Vol. 8 No. 3 |
208 |
Emollient Lip Balm with 5% Benzocaine |
Vol. 8 No. 3 |
208 |
Fever Blister Ointment |
Vol. 8 No. 3 |
208 |
Deoxy-D-Glucose 0.2%, Lidocaine HCl 5% and Sodium Lauryl Sulfate 5% Cream |
Vol. 8 No. 3 |
208 |
Lemon Balm 1% Cream |
Vol. 8 No. 3 |
209 |
Acyclovir 5% and Lidocaine HCl 2% Topical Gel |
Vol. 8 No. 3 |
209 |
Acyclovir 5% and Sodium Lauryl Sulfate 5% Topical Gel |
Vol. 8 No. 3 |
209 |
Foscarnet 3% and Sodium Lauryl Sulfate 5% Topical Gel |
Vol. 8 No. 3 |
209 |
Acyclovir 5% and Dexamethasone 0.1% Topical Gel |
Vol. 8 No. 3 |
209 |
Foscarnet 3% and Triamcinolone Acetonide 0.1% Topical Gel |
Vol. 8 No. 3 |
209 |
Standard Operating Procedure: Disposal of Chemicals |
Vol. 8 No. 3 |
210 |
Calculations |
Vol. 8 No. 3 |
211 |
Alpha Hydroxy Acids Lotion |
Vol. 8 No. 3 |
213 |
Amiodarone HCl 5-mg/mL Oral Liquid |
Vol. 8 No. 3 |
214 |
Atenolol 2-mg/mL Oral Liquid |
Vol. 8 No. 3 |
215 |
Clonidine HCl 1.5-mg/mL Injection |
Vol. 8 No. 3 |
216 |
Fluorouracil 1% Ophthalmic Solution |
Vol. 8 No. 3 |
217 |
Glycopyrrolate 0.5-mg/mL Oral Liquid |
Vol. 8 No. 3 |
218 |
Ketoprofen 50-mg Suppository |
Vol. 8 No. 3 |
219 |
Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection |
Vol. 8 No. 3 |
220 |
Sumatriptan 25-mg Suppository |
Vol. 8 No. 3 |
221 |
Testosterone Propionate 100-mg/mL in Oil Injection |
Vol. 8 No. 3 |
222 |
Quality-Control Analytical Methods: High-Performance Liquid Chromatography |
Vol. 8 No. 3 |
223 |
Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs. |
Vol. 8 No. 3 |
228 |
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. |
Vol. 8 No. 3 |
231 |
Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours. |
Vol. 8 No. 3 |
236 |
PostScription: How should a pharmacist be trained? |
Vol. 8 No. 3 |
240 |
PreScription - Categories of Pharmaceutial Compounding |
Vol. 8 No. 4 |
242 |
Book and Literature Reviews |
Vol. 8 No. 4 |
244 |
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards |
Vol. 8 No. 4 |
251 |
Case Report: Wound Care of a Diabetic Foot Ulcer |
Vol. 8 No. 4 |
265 |
Case Reports: Their Impact |
Vol. 8 No. 4 |
266 |
Current Topical Treatments in Wound Healing - Part 1 |
Vol. 8 No. 4 |
269 |
Warts: Facts and Therapy (Patient Handout) |
Vol. 8 No. 4 |
275 |
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2 |
Vol. 8 No. 4 |
277 |
Rationale for a Pharmacists' Pharmacopeia |
Vol. 8 No. 4 |
285 |
Basics of Compounding for Fungal Sinusitis |
Vol. 8 No. 4 |
289 |
Amphotericin 100-mcg/mL Nasal Irrigation/Spray |
Vol. 8 No. 4 |
290 |
Ketoconazole 1% Nasal Irrigation/Spray |
Vol. 8 No. 4 |
290 |
Miconazole 1% Nasal Irrigation/Spray |
Vol. 8 No. 4 |
290 |
Nystatin 50,000-Units/mL Nasal Irrigation |
Vol. 8 No. 4 |
290 |
Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product |
Vol. 8 No. 4 |
292 |
Calculations |
Vol. 8 No. 4 |
294 |
Diltiazem 2% in Pluronic Lecithin Organogel |
Vol. 8 No. 4 |
295 |
Diphenhydramine HCl 0.1%, Lidocaine HCl 1%, Misoprostol 0.0024% and Triamcinolone Acetonide 0.12% Oral Rinse |
Vol. 8 No. 4 |
296 |
Estradiol 0.01% Wound Gel |
Vol. 8 No. 4 |
297 |
Lidocaine HCl 2%, Misoprostol 0.0024% and Phenytoin 2% Topical Wound Powder |
Vol. 8 No. 4 |
298 |
Metronidazole 2%, Misoprostol 0.0024% and Phenytoin 5% Topical Gel |
Vol. 8 No. 4 |
299 |
Metronidazole 2% Topical Gel |
Vol. 8 No. 4 |
300 |
Pentoxifylline 5% Topical Cream |
Vol. 8 No. 4 |
301 |
Tretinoin 0.1% and Lidocaine HCl 0.5% Topical Gel |
Vol. 8 No. 4 |
302 |
Veterinary Wound Dressing |
Vol. 8 No. 4 |
303 |
Wound Cleansing Spray |
Vol. 8 No. 4 |
304 |
Quality-Control Analytical Methods: Gas Chromatography |
Vol. 8 No. 4 |
305 |
Enhanced Release of Diazepam from Hollow-Type Suppositories |
Vol. 8 No. 4 |
310 |
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy |
Vol. 8 No. 4 |
313 |
PostScription: What is Evidence-Based Medicine? |
Vol. 8 No. 4 |
320 |
Prescription: Accreditation of Pharmacies and Certification of Pharmacists |
Vol. 8 No. 5 |
322 |
Book and Literature Reviews |
Vol. 8 No. 5 |
324 |
Domperidone in Lactation: Use as a Galactagogue |
Vol. 8 No. 5 |
329 |
Domperidone Capsules 10-, 20- and 30-mg |
Vol. 8 No. 5 |
332 |
Case Report: Diagnosis and Management of Trigeminal Neuralgia and Chronic Paroxysmal Hemicrania in a 43-Year-Old Woman – Oral and Transmucosal Pharmacologic Medications |
Vol. 8 No. 5 |
337 |
Head to Toe Solutions: A Quick Review of Current Therapies |
Vol. 8 No. 5 |
345 |
Aromatic Head Lice Oil |
Vol. 8 No. 5 |
346 |
Current Topical Treatments in Wound Healing - Part 2 |
Vol. 8 No. 5 |
354 |
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3 |
Vol. 8 No. 5 |
359 |
Wish You Were Here: American Institute of the History of Pharmacy, Madison, Wisconsin |
Vol. 8 No. 5 |
368 |
A Foot in the Door: Marketing Tips - Dealing With Personalities |
Vol. 8 No. 5 |
373 |
Basics of Compounding for Skin Discolorations |
Vol. 8 No. 5 |
376 |
Hydroquinone 5% Cream |
Vol. 8 No. 5 |
378 |
Hydroquinone 5% in Isopropyl Alcohol |
Vol. 8 No. 5 |
378 |
Hydroquinone 5% Topical Gel |
Vol. 8 No. 5 |
378 |
Hydroquinone 5% Topical Stick, Water Repellant |
Vol. 8 No. 5 |
378 |
Hydroquinone 5% Topical Stick, Water Soluble |
Vol. 8 No. 5 |
378 |
Dexamethasone 0.1%, Hydroquinone 5% and Retinoic Acid 0.1% Ointment |
Vol. 8 No. 5 |
378 |
Hydroquinone 5%, Retinoic Acid 0.1% and Triamcinolone 0.1% Gel |
Vol. 8 No. 5 |
378 |
Hydroquinone 5%, Retinoic Acid 0.1% and Triamcinolone 0.1% Cream |
Vol. 8 No. 5 |
378 |
Hydroquinone 5%, Retinoic Acid 0.1% and Triamcinolone 0.1% Ointment |
Vol. 8 No. 5 |
379 |
Hydrocortisone 1%, Hydroquinonne 5% and Glycolic Acid 5% Lotion |
Vol. 8 No. 5 |
379 |
Standard Operating Procedure: Pharmacy Computer System Access to and Maintenance of the Master Formula Records |
Vol. 8 No. 5 |
381 |
Calculations |
Vol. 8 No. 5 |
382 |
Acyclovir 5% and Chlorhexidine Diacetate 0.2% Topical Gel |
Vol. 8 No. 5 |
383 |
Benzalkonium Chloride 0.1% Topical Gel |
Vol. 8 No. 5 |
384 |
Camphor 0.3%, Menthol 0.3% and Phenol 0.3% Topical Gel |
Vol. 8 No. 5 |
385 |
Coal Tar 1% Topical Gel |
Vol. 8 No. 5 |
386 |
Diclofenac Sodium 1.5% Topical Gel |
Vol. 8 No. 5 |
387 |
Ibuprofen 2% Topical Gel |
Vol. 8 No. 5 |
388 |
Ketamine HCl 5% and Ketoprofen 5% in PLO |
Vol. 8 No. 5 |
389 |
Ketoprofen 5% and Loperamide 7.5% in PLO |
Vol. 8 No. 5 |
390 |
Resorcinol 1% and Salicylic Acid 3% Gel |
Vol. 8 No. 5 |
391 |
Salicylic Acid 6% Topical Gel |
Vol. 8 No. 5 |
392 |
Quality-Control Analytical Methods: USP Chapter <797> Compounded Sterile Preparations Sterility Requirements and Their Relationship to Beyond-Use Dating |
Vol. 8 No. 5 |
393 |
Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate |
Vol. 8 No. 5 |
398 |
Chemical Stability of Terbutaline Sulfate Injection After Diluting With Normal Saline When Stored at Room Temperature in Polyvinylchloride Bags |
Vol. 8 No. 5 |
404 |
PostScription: Your voice is important to the future of pharmacy |
Vol. 8 No. 5 |
407 |
PreScription: US Pharmacopeia-US Dispensatory: Pharmacist's Edition |
Vol. 8 No. 6 |
410 |
Book Review: HRT: The Answers. A Concise Guide for Solving the Hormone Replacement Therapy Puzzle |
Vol. 8 No. 6 |
412 |
Book Review: Good to Great: Why Some Companies Make the Leap and Others Don't |
Vol. 8 No. 6 |
412 |
Literature Reviews |
Vol. 8 No. 6 |
413 |
Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate? |
Vol. 8 No. 6 |
419 |
The Salivary Hormone Profile in the Clinical Evaluation of Women |
Vol. 8 No. 6 |
427 |
Compounding for the Dental Patient: A Focus on Ulcers of the Mouth |
Vol. 8 No. 6 |
436 |
Compounding for Sports Medicine |
Vol. 8 No. 6 |
443 |
Is Veterinary Compounding Illegal Under Federal Law? |
Vol. 8 No. 6 |
449 |
Cleaning of Isolators: A Vital Part of a Contamination Control Program |
Vol. 8 No. 6 |
452 |
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid |
Vol. 8 No. 6 |
458 |
Basics of Compounding for Cough |
Vol. 8 No. 6 |
462 |
Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations |
Vol. 8 No. 6 |
466 |
Calculations |
Vol. 8 No. 6 |
468 |
BAD (Benadryl, Ativan, and Decadron) Intravenous Drip |
Vol. 8 No. 6 |
469 |
Diclofenac Sodium 25-mg/mL Injection |
Vol. 8 No. 6 |
470 |
Gentamicin Sulfate, Neomycin Sulfate, and Polymixin B Sulfate Bladder Irrigation |
Vol. 8 No. 6 |
471 |
Gentamicin Sulfate 0.2%, Misoprostol 0.0024%, and Phenytoin 5% Topical Gel |
Vol. 8 No. 6 |
472 |
Itraconazole 0.1% Nasal Irrigation |
Vol. 8 No. 6 |
473 |
Ketamine Hydrochloride and Fentanyl Citrate Injection |
Vol. 8 No. 6 |
474 |
Ketamine 25-mg/mL Nasal Spray |
Vol. 8 No. 6 |
475 |
Lidocaine Hydrochloride 4%, Epinephrine Hydrochloride 0.05%, and Tetracaine Hydrochloride 0.5% Topical Spray |
Vol. 8 No. 6 |
476 |
Ofloxacin 0.5% Topical Liquid |
Vol. 8 No. 6 |
477 |
Sodium Hypochlorite 0.025% Topical Solution |
Vol. 8 No. 6 |
478 |
Quality-Control Analytical Methods: Allowable Endotoxic Levels in Sterile Preparations |
Vol. 8 No. 6 |
479 |
Stability of Extemporaneous Oral Ribavirin Liquid Preparation |
Vol. 8 No. 6 |
486 |
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink |
Vol. 8 No. 6 |
489 |
Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension |
Vol. 8 No. 6 |
492 |
PostScription |
Vol. 8 No. 6 |
496 |